ストックスクリーナーアプリを入手
10.31
0.10%
-0.010
アフターアワーズ：
10.31
前日終値:
$10.32
開ける：
$10.31
24時間の取引高:
20,158
Relative Volume:
0.52
時価総額：
$345.56M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.05%
1か月 パフォーマンス:
+0.39%
6か月 パフォーマンス:
+2.18%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$10.31
$10.31
1週間の範囲:
$10.30
$10.35
52週間の値動き範囲:
$9.96
$10.35
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
名前
Drugs Made In America Acquisition Corp
セクター
電話
954-870-3104
住所
2 PELICAN DR., FORT LAUDERDALE
DMAA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.31 | 345.90M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.43 | 1.82B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
CCCX
Churchill Capital Corp X
|
19.26 | 929.61M | 0 | 0 | 0 | 0.00 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.03 | 591.41M | 0 | 0 | 0 | 0.00 |
|
AEXA
American Exceptionalism Acquisition Corp A
|
11.55 | 567.81M | 0 | 0 | 0 | 0.00 |
|
AAM
Aa Mission Acquisition Corp
|
10.60 | 464.37M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp (DMAA) 最新ニュース
Strategies to average down on Drugs Made In America Acquisition Corp.Swing Trade & Technical Pattern Based Buy Signals - newser.com
News impact scoring models applied to Drugs Made In America Acquisition Corp.July 2025 Fed Impact & Verified Swing Trading Watchlist - newser.com
Full technical analysis of Drugs Made In America Acquisition Corp. Equity Right stock - newser.com
Is Drugs Made In America Acquisition Corp. stock trading near support levelsMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
Published on: 2025-11-02 12:34:43 - newser.com
What technical models suggest about Drugs Made In America Acquisition Corp. Equity Right’s comebackJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Is Drugs Made In America Acquisition Corp. Equity Right trending in predictive chart modelsJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Is Drugs Made In America Acquisition Corp. stock a dividend growth opportunityJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Using data models to predict Drugs Made In America Acquisition Corp. stock movementJuly 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
Pattern recognition hints at Drugs Made In America Acquisition Corp. upsideEarnings Growth Summary & Short-Term High Return Strategies - newser.com
Pfizer Inc. - Britannica
Op-Ed: Jared Whitley: Consolidation in weight loss R&D would jeopardize President Trump’s drug pricing wins - Washington Reporter
How Drugs Made In America Acquisition Corp. Equity Right stock reacts to bond yields2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Will VRNA stock reach Wall Street targetsExit Point & Daily Technical Forecast Reports - newser.com
Published on: 2025-10-31 05:15:32 - newser.com
Real time breakdown of Drugs Made In America Acquisition Corp. stock performanceQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Why analysts upgrade Drugs Made In America Acquisition Corp. stockPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com
How to track smart money flows in Drugs Made In America Acquisition Corp. Equity RightWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
How Drugs Made In America Acquisition Corp. stock valuations compare to rivalsGap Up & Smart Investment Allocation Insights - newser.com
Published on: 2025-10-30 23:22:41 - newser.com
Drugs Made In America Acquisition Corp. stock chart pattern explained2025 Performance Recap & Entry Point Strategy Guides - newser.com
How to read the order book for Drugs Made In America Acquisition Corp.Insider Buying & Expert Verified Stock Movement Alerts - newser.com
Custom strategy builders for tracking Drugs Made In America Acquisition Corp. Equity RightQuarterly Profit Summary & Smart Money Movement Alerts - newser.com
Drugs Made In America Acquisition Corp (DMAA) 財務データ
Drugs Made In America Acquisition Corp (DMAA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.09%
0.20%
大文字化:
|
ボリューム (24 時間):